Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

New Nordic Healthbrands Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Karl Kristian Jensen

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	34.8yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	4.8yrs
Yönetim Kurulu ortalama görev süresi	15.8yrs

Son yönetim güncellemeleri

Recent updates

New Nordic Healthbrands AB (publ)'s (STO:NNH) Popularity With Investors Is Clear

Jul 03

These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well

Oct 30

New Nordic Healthbrands (STO:NNH) Will Be Hoping To Turn Its Returns On Capital Around

Jul 31

Calculating The Intrinsic Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Jun 08

Estimating The Fair Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Mar 08

These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well

Feb 15

What Do The Returns On Capital At New Nordic Healthbrands (STO:NNH) Tell Us?

Jan 25

Should New Nordic Healthbrands AB (publ) (STO:NNH) Be Part Of Your Dividend Portfolio?

Dec 31

New Nordic Healthbrands AB (publ)'s (STO:NNH) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Dec 09

CEO

Karl Kristian Jensen (62 yo)

34.8yrs

Görev süresi

Mr. Karl Kristian Bergman Jensen, VD co-founded New Nordic Health Brands AB (publ) in 1990 and has been its Chief Executive Officer & Director since 2006. Prior to that, Mr. Jensen served as International...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Karl Kristian Jensen	Co-Founder	34.8yrs	Veri yok	Veri yok
Marinus Sorensen	Co-Founder & Chairman	18.8yrs	Veri yok	37.43% SEK 37.3m
Ivan Ruscic	Chief Financial Officer	4.4yrs	Veri yok	Veri yok
Claes Libell	Group Financial Controller & Investor Relations	4.8yrs	Veri yok	Veri yok

4.8yrs

Ortalama Görev Süresi

Deneyimli Yönetim: NNH 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Karl Kristian Jensen	Co-Founder	18.8yrs	Veri yok	Veri yok
Marinus Sorensen	Co-Founder & Chairman	18.8yrs	Veri yok	37.43% SEK 37.3m
Lennart Sjölund	Director	12.8yrs	Veri yok	0.16% SEK 161.0k
Kirsten Aegidius	Director	2.5yrs	Veri yok	Veri yok

15.8yrs

Ortalama Görev Süresi

67.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: NNH 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 15.8 yıldır).

New Nordic Healthbrands Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

New Nordic Healthbrands AB (publ) Part Ways with Tage Juhl Finninge, Chief Commercial and Operating Officer

Chief Commercial Officer & COO recently bought kr140k worth of stock

Chief Commercial Officer & COO recently bought kr202k worth of stock

Chief Commercial Officer & COO recently bought kr103k worth of stock

No independent directors

New Nordic Healthbrands AB (publ) Appoints Tage Juhl Finninge as New Chief Commercial and Operating Officer

Recent updates

New major risk - Market cap size

Second quarter 2024 earnings released: kr0.72 loss per share (vs kr0.50 loss in 2Q 2023)

New Nordic Healthbrands AB (publ)'s (STO:NNH) Popularity With Investors Is Clear

First quarter 2024 earnings released: kr0.55 loss per share (vs kr0.094 profit in 1Q 2023)

New Nordic Healthbrands AB (publ) to Report Fiscal Year 2024 Results on Feb 28, 2025

New Nordic Healthbrands (STO:NNH) Is Making Moderate Use Of Debt

Third quarter 2023 earnings released: EPS: kr0.33 (vs kr1.16 in 3Q 2022)

New major risk - Market cap size

New Nordic Healthbrands AB (publ) Part Ways with Tage Juhl Finninge, Chief Commercial and Operating Officer

Does New Nordic Healthbrands (STO:NNH) Have A Healthy Balance Sheet?

Second quarter 2023 earnings released: kr0.50 loss per share (vs kr1.21 loss in 2Q 2022)

Is New Nordic Healthbrands (STO:NNH) A Risky Investment?

First quarter 2023 earnings released: EPS: kr0.094 (vs kr0.16 in 1Q 2022)

Chief Commercial Officer & COO recently bought kr140k worth of stock

Full year 2022 earnings released: kr0.46 loss per share (vs kr3.44 profit in FY 2021)

Chief Commercial Officer & COO recently bought kr202k worth of stock

Chief Commercial Officer & COO recently bought kr103k worth of stock

Is New Nordic Healthbrands (STO:NNH) Using Too Much Debt?

No independent directors

Third quarter 2022 earnings released: EPS: kr1.16 (vs kr1.08 in 3Q 2021)

Investor sentiment improved over the past week

New Nordic Healthbrands AB (publ) Appoints Tage Juhl Finninge as New Chief Commercial and Operating Officer

Now 24% undervalued after recent price drop

Calculating The Fair Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Now 20% undervalued after recent price drop

Capital Allocation Trends At New Nordic Healthbrands (STO:NNH) Aren't Ideal

Investor sentiment deteriorated over the past week

New Nordic Healthbrands (STO:NNH) Has A Pretty Healthy Balance Sheet

Investor sentiment improved over the past week

Director recently bought kr102k worth of stock

Director recently bought kr91k worth of stock

Investor sentiment deteriorated over the past week

Capital Investment Trends At New Nordic Healthbrands (STO:NNH) Look Strong

No independent directors

Upcoming dividend of kr1.25 per share

Co-Founder recently sold kr316k worth of stock

Full year 2021 earnings released: EPS: kr3.44 (vs kr2.87 in FY 2020)

Director recently bought kr123k worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Is New Nordic Healthbrands (STO:NNH) Using Too Much Debt?

Co-Founder recently sold kr386k worth of stock

Co-Founder recently sold kr378k worth of stock

Co-Founder recently sold kr196k worth of stock

Co-Founder recently sold kr155k worth of stock

Investor sentiment deteriorated over the past week

These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well

Co-Founder recently sold kr147k worth of stock

Second quarter 2021 earnings released: EPS kr1.41 (vs kr0.53 in 2Q 2020)

New Nordic Healthbrands (STO:NNH) Will Be Hoping To Turn Its Returns On Capital Around

Investor sentiment improved over the past week

Calculating The Intrinsic Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Investor sentiment improved over the past week

Upcoming dividend of kr1.50 per share

Full year 2020 earnings released: EPS kr2.87 (vs kr4.53 in FY 2019)

Estimating The Fair Value Of New Nordic Healthbrands AB (publ) (STO:NNH)

Full year 2020 earnings released: EPS kr2.87 (vs kr4.53 in FY 2019)

New 90-day low: kr55.80

These 4 Measures Indicate That New Nordic Healthbrands (STO:NNH) Is Using Debt Reasonably Well

What Do The Returns On Capital At New Nordic Healthbrands (STO:NNH) Tell Us?

Should New Nordic Healthbrands AB (publ) (STO:NNH) Be Part Of Your Dividend Portfolio?

New Nordic Healthbrands AB (publ)'s (STO:NNH) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

New 90-day low: kr56.00

Third quarter 2020 earnings released: EPS kr1.04

New 90-day low: kr56.20

New 90-day low - kr56.80

New 90-day high - kr67.00

New Nordic Healthbrands AB (publ) to Report First Half, 2020 Results on Jul 31, 2020

CEO